This statistic displays the projected treatment expenditures of selected diseases in the United States from 2010 to 2035, sorted by extent of medtech incentives. Under continued incentives in medical technology, heart diseases would have treatment expenditures totaling almost 2.7 trillion U.S. dollars during these years. The direct economic benefit of medical technology such as devices and diagnostics is simple to measure, however, including indirect costs such as reducing the length of hospital stays is more complex to find.
Projected treatment expenditures of selected diseases in the U.S. from 2010 to 2035, by extent of medtech incentives (in billion U.S. dollars)*
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Milken Institute. (July 23, 2014). Projected treatment expenditures of selected diseases in the U.S. from 2010 to 2035, by extent of medtech incentives (in billion U.S. dollars)* [Graph]. In Statista. Retrieved November 21, 2024, from https://www.statista.com/statistics/319444/treatment-expenditures-of-diseases-in-the-us-by-medtech-incentives/
Milken Institute. "Projected treatment expenditures of selected diseases in the U.S. from 2010 to 2035, by extent of medtech incentives (in billion U.S. dollars)*." Chart. July 23, 2014. Statista. Accessed November 21, 2024. https://www.statista.com/statistics/319444/treatment-expenditures-of-diseases-in-the-us-by-medtech-incentives/
Milken Institute. (2014). Projected treatment expenditures of selected diseases in the U.S. from 2010 to 2035, by extent of medtech incentives (in billion U.S. dollars)*. Statista. Statista Inc.. Accessed: November 21, 2024. https://www.statista.com/statistics/319444/treatment-expenditures-of-diseases-in-the-us-by-medtech-incentives/
Milken Institute. "Projected Treatment Expenditures of Selected Diseases in The U.S. from 2010 to 2035, by Extent of Medtech Incentives (in Billion U.S. Dollars)*." Statista, Statista Inc., 23 Jul 2014, https://www.statista.com/statistics/319444/treatment-expenditures-of-diseases-in-the-us-by-medtech-incentives/
Milken Institute, Projected treatment expenditures of selected diseases in the U.S. from 2010 to 2035, by extent of medtech incentives (in billion U.S. dollars)* Statista, https://www.statista.com/statistics/319444/treatment-expenditures-of-diseases-in-the-us-by-medtech-incentives/ (last visited November 21, 2024)
Projected treatment expenditures of selected diseases in the U.S. from 2010 to 2035, by extent of medtech incentives (in billion U.S. dollars)* [Graph], Milken Institute, July 23, 2014. [Online]. Available: https://www.statista.com/statistics/319444/treatment-expenditures-of-diseases-in-the-us-by-medtech-incentives/
